Dark Forest Capital Management LP Alkermes Plc. Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $958,421 - $1.13 Million	35,275 Added 133.86%	61,628 $1.73 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $691,155 - $820,168	24,388 Added 1241.12%	26,353 $824,000
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $49,734 - $57,024	1,965 New	1,965 $55,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $7,084 - $10,262	322 Added 1150.0%	350 $8,000
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $739 - $855	28 New	28 $1,000
Q4 2021 Feb 11, 2022	SELL	$21.47 - $32.08 $10,949 - $16,360	-510 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $11,918 - $16,386	510 New	510 $16,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.